F627-0071 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide

F627-0071 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide
F627-0071 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F627-0071
N-(2H-1,3-benzodioxol-5-yl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F627-0071

Molecular Formula

C21H21N5O4 (C21 H21 N5 O4)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-4-[4-(5-methyl-124-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide

SMILES

Cc1nc(-c(cc2)ccc2N(CC2)CCN2C(Nc(cc2)cc3c2OCO3)=O)no1

InChI

InChI=1S/C21H21N5O4/c1-14-22-20(24-30-14)15-2-5-17(6-3-15)25-8-10-26(11-9-25)21(27)23-16-4-7-18-19(12-16)29-13-28-18/h2-7,12H,8-11,13H2,1H3,(H,23,27)

InChI Key

PRKBJYFYSDQYGM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27179799

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.384

Distribution Coefficient, logD

3.384

Water Solubility, LogSw

-3.57

Polar Surface Area

76.989

Acid Dissociation Constant (pKa)

12.72

Base Dissociation Constant (pKb)

3.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

F627-0071 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F627-0071 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F627-0071?
Check Price and Availability of F627-0071, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F627-0071 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F627-0071
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F627-0071
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F627-0071 available by request